Nature of business and basis of presentation (Details)	1 Months Ended
	Sep. 30, 2019 $ / shares	Dec. 31, 2019 USD ($) $ / shares	Dec. 31, 2018 $ / shares
Cash balance | $		$ 130,088,869
Common stock, par value	$ 0.001	$ 0.001	$ 0.11
Aprea Therapeutics AB
Common stock, par value	$ 0.11
Convertible preferred stock | Aprea Therapeutics AB
Conversion ratio	1
Common Stock | Aprea Therapeutics AB
Conversion ratio	1